ADMA Biologics Inc (ADMA)
23.32
+3.60
(+18.26%)
USD |
NASDAQ |
Nov 08, 13:50
ADMA Biologics Revenue (TTM): 330.24M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 330.24M |
March 31, 2024 | 283.18M |
December 31, 2023 | 258.22M |
September 30, 2023 | 234.29M |
June 30, 2023 | 208.11M |
March 31, 2023 | 181.89M |
December 31, 2022 | 154.08M |
September 30, 2022 | 130.48M |
June 30, 2022 | 110.07M |
March 31, 2022 | 94.00M |
December 31, 2021 | 80.94M |
September 30, 2021 | 68.52M |
June 30, 2021 | 58.11M |
March 31, 2021 | 48.07M |
December 31, 2020 | 42.22M |
September 30, 2020 | 40.30M |
June 30, 2020 | 37.25M |
March 31, 2020 | 36.02M |
December 31, 2019 | 29.35M |
September 30, 2019 | 21.37M |
June 30, 2019 | 18.38M |
March 31, 2019 | 16.47M |
December 31, 2018 | 16.99M |
September 30, 2018 | 24.93M |
Date | Value |
---|---|
June 30, 2018 | 25.43M |
March 31, 2018 | 24.17M |
December 31, 2017 | 22.76M |
September 30, 2017 | 14.09M |
June 30, 2017 | 12.29M |
March 31, 2017 | 11.17M |
December 31, 2016 | 10.66M |
September 30, 2016 | 9.846M |
June 30, 2016 | 8.760M |
March 31, 2016 | 7.798M |
December 31, 2015 | 7.178M |
September 30, 2015 | 6.154M |
June 30, 2015 | 5.668M |
March 31, 2015 | 5.858M |
December 31, 2014 | 5.916M |
September 30, 2014 | 4.851M |
June 30, 2014 | 4.592M |
March 31, 2014 | 3.835M |
December 31, 2013 | 3.068M |
September 30, 2013 | 3.167M |
June 30, 2013 | 2.420M |
March 31, 2013 | 1.907M |
December 31, 2012 | 1.118M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
29.35M
Minimum
Dec 2019
330.24M
Maximum
Jun 2024
127.65M
Average
94.00M
Median
Mar 2022
Revenue (TTM) Benchmarks
Corcept Therapeutics Inc | 628.56M |
Assembly Biosciences Inc | -- |
TG Therapeutics Inc | 264.79M |
Varex Imaging Corp | 832.70M |
Krystal Biotech Inc | 241.52M |